For decades, Kathy Steece-Collier, PhD, professor of translational neuroscience, has been researching ways to improve the quality of life for Parkinson’s patients. Her work has led to a new gene therapy that could reduce or eliminate symptoms. Evidence also suggests this therapy has potential to halt progression of the disease.
Jack Lipton, PhD, founding chair of the Department of Translational Neuroscience, recently joined the Office of Research to help unit leaders use data to predict and improve performance.
See the latest awards and grants received by TransNeuro faculty.
The Department of Translational Neuroscience invites you and your family to the MSU Neuroscience Fair on March 16 at the Grand Rapids Public Museum. Meet scientists and learn about the marvels of the brain – from how it looks, feels and works to how to keep it healthy.
Crain's Grand Rapids Business named Jack Lipton, PhD, a notable West Michigan leader in health care.
Several TransNeuro faculty members have made headlines recently.
In a recent WLNS news story, Irving Vega, PhD, discusses research indicating Hispanic Americans are at higher risk of developing Alzheimer’s disease.
Michigan State University neuroscientist Irving Vega is often found in his lab studying the impact certain proteins have on the development of neurodegenerative disorders like Alzheimer’s disease. But when he’s not conducting research, Vega makes time to go out into the community to talk about Alzheimer’s disease and engage with students about their interest in science.
Jack Lipton, PhD, chair of the Department of Translational Neuroscience, was elected the next chair of the university’s Faculty Senate.
A new startup, CavGene Therapeutics, Inc., will further research initiated by Kathy Steece-Collier, PhD, a professor of Translational Neuroscience in the College of Human Medicine. For decades, she has led an effort to reduce or eliminate a frequent side effect of a drug commonly prescribed for Parkinson’s patients.
The Department of Translational Neuroscience hosted the event at the Grand Rapids Public Museum where participants experienced 17 hands-on activities like performing deep brain stimulation on a gelatin brain, extracting DNA from a banana and viewing neurons under the microscope.
Irving Vega, PhD, has taken on additional responsibilities as the director of a program at MSU to increase diversity in the neurosciences, much like one at the University of Puerto Rico that encouraged and helped him keep studying toward a research career.
Caryl Sortwell, PhD, professor, has been named the recipient of the Edwin A. Brophy Chair in Central Nervous System Disorders.
Irving Vega, PhD, was named Red Cedar Distinguished Faculty for his research in Alzheimer's disease and engagement with the community.
As the novel coronavirus continues to spread around the globe, a more accurate test that can detect the virus much earlier than other tests has been adapted and validated by Michigan State University researchers
Jack Lipton, PhD, and Caryl Sortwell, PhD, co-authored the op-ed “We Have a Coronavirus Test – Let us use it” published in the Wall Street Journal.
As we all adapt to new ways of connecting with our community, Michigan State University College of Human Medicine and a group of local crafters have teamed up to solve a problem and fulfill a statewide need.
Dr. David Morgan is leading new study called Preventing Alzheimer's with Cognitive Training, which looks at whether or not computerized training exercises or brain games can reduce the risk of dementia.
The Department of Translational Science & Molecular Medicine has changed its name to more accurately reflect its research mission. We are now the Department of Translational Neuroscience!
The Michael J. Fox Foundation awarded Dr. Sortwell more than $280,000 for Parkinson's research.